Will Plavix be the next drug up for a genetic test? There are not many alternative drugs either that could easily replace the functionality of Plavix, it is a blood thinner. One idea would be to monitor patients with poor liver or kidney metabolization. as suggested here , a blog written...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-02-2009
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
This is a very good point, getting all the data organized into a fashion where it can be used and analyzed. Back a few months ago when I interviewed Patrice Milos, Vice President and Chief Scientific Officer, of Helicos BioSciences I asked the same question, and also if each interpretation would...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, DNA, Genomics, healthcare, microsoft, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
Let’s put it another way, it can’t exist without IT. Again it all comes back to running algorithms to obtain desired results. As I have mentioned before, Algorithms is one of the hottest words right now in healthcare as we all make decisions from queried results. A while back I had the opportunity...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-25-2008
Filed under:
Filed under: Medically Related, Technology, Microsoft/Windows News, EMR, personalized medicine, DNA, Genomics, healthcare, microsoft, Medical Records, EHR, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...